NCT02371694

Brief Summary

Background: Based on international evidence, current management of people with T1DM on intensive insulin therapy (IIT) use algorithms based on the meal carbohydrate content (MCC) to calculate the prandial insulin dose. Typically, these calculations do not take into account the protein or fat content of the meal. There is a lack of clinical advice for optimal management of high protein/fat meals due to a paucity of evidence regarding the impact of protein/fat on glycaemic control. Objective: To determine the mean glucose excursion from fasting (measured by continuous glucose monitoring, CGMS) at each 30 minute interval over the 8 hour postprandial period for each test condition. Protein effects will be looked at in a separate parallel study in Australia. Hypothesis: The fat content of a meal will cause a dose-response change in the postprandial glucose concentration in children with T1DM. Research Design and Methods: Randomised cross-over study involving thirty patients. Inclusion criteria: T1DM \>1 year, aged 8-18 years, with HbA1c \<8% and BMI \<91st centile, on intensive insulin therapy. Participants will be given a test meal on 6 consecutive nights in random order; 4 test meals varying in fat content, and one 20g carbohydrate test meal with zero fat given as control meal. A CGMS will be used to assess glucose responses at 5 minute intervals for 8 hours after test meal consumption. The relationship between the fat loads in the test meals and the mean change in postprandial glucose concentration will be analysed and described. Conclusions: This study will determine whether fat causes dose dependent response in glucose concentrations leading to refining the guidelines and possible adjustment of insulin doses for the fat content of a meal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 26, 2015

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

August 20, 2019

Status Verified

August 1, 2019

Enrollment Period

3.9 years

First QC Date

February 19, 2015

Last Update Submit

August 16, 2019

Conditions

Keywords

LipidCarbohydrate countingAdolescentContinuous glucose monitoringInsulin requirements

Outcome Measures

Primary Outcomes (1)

  • Glycaemic excursion

    The mean glucose excursion from fasting (measured by CGMS) at each 30 minute interval over the 8 hour postprandial period for each test condition

    During the 8 hours post drink

Secondary Outcomes (5)

  • Maximal glucose excursion

    During the 24h post drink

  • Time to maximal glucose excursion

    During the 8 hours post drink

  • Time until the glucose level returns to baseline

    During the 8 hours post drink

  • Percent time in target glucose range

    During the 24h post drink

  • Number of hypoglycaemic events in the 24h post-test meal

    During the 24 hours post drink

Study Arms (6)

Fat Test drink (50g)

EXPERIMENTAL

This drink contains 50g sunflower oil and vehicle (almond milk, chocolate drink powder, sweetener)

Other: Test drink

Fat Test drink (38g)

EXPERIMENTAL

This drink contains 38g sunflower oil and vehicle (almond milk, chocolate drink powder, sweetener)

Other: Test drink

Fat Test drink (25g)

EXPERIMENTAL

This drink contains 25g sunflower oil and vehicle (almond milk, chocolate drink powder, sweetener)

Other: Test drink

Fat Test drink (13g)

EXPERIMENTAL

This drink contains 13g sunflower oil and vehicle (almond milk, chocolate drink powder, sweetener)

Other: Test drink

Fat Test drink (3g)

PLACEBO COMPARATOR

This drink contains no sunflower oil and vehicle (almond milk, chocolate drink powder, sweetener)

Other: Test drink

Carbohydrate Test drink

ACTIVE COMPARATOR

This drink contains 20g of glucose from de-gassed lucozade energy.

Other: Test drink

Interventions

The intervention is a drink taken 4 hours after the evening meal insulin injection, or 10PM, whichever is later. All drinks are 116-120g in weight and similar volume. All drinks are served in a double blind fashion, apart from the 20g carbohydrate which is visibly different from other drinks in colour, texture and flavour.

Carbohydrate Test drinkFat Test drink (13g)Fat Test drink (25g)Fat Test drink (38g)Fat Test drink (3g)Fat Test drink (50g)

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed with T1DM for more than 1 year
  • HbA1c less than 8%
  • BMI less than 91st centile
  • on intensive insulin therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cork University Hospital

Cork, T12 DC4A, Ireland

Location

Related Publications (1)

  • Pankowska E, Szypowska A, Lipka M, Szpotanska M, Blazik M, Groele L. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes. 2009 Aug;10(5):298-303. doi: 10.1111/j.1399-5448.2008.00471.x. Epub 2008 Oct 20.

    PMID: 19175902BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Susan O'Connell, MD

    Cork University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Paediatric Endocrinologist

Study Record Dates

First Submitted

February 19, 2015

First Posted

February 26, 2015

Study Start

February 1, 2015

Primary Completion

December 30, 2018

Study Completion

December 30, 2018

Last Updated

August 20, 2019

Record last verified: 2019-08

Locations